Recombinant Saccharomyces cerevisiae ADP,ATP carrier protein 2 (PET9)

What is PET9 and what is its primary function in Saccharomyces cerevisiae?

PET9 (also known as AAC2) is the major ADP/ATP carrier protein located in the mitochondrial inner membrane of Saccharomyces cerevisiae. Its primary function is to exchange cytosolic ADP for mitochondrially synthesized ATP, thereby serving as a critical link between energy production in mitochondria and energy utilization in the cytosol. PET9 also imports heme and ATP and is required for viability in many laboratory strains that carry a sal1 mutation . The protein consists of 309 amino acids and exhibits high homology with mitochondrial translocator proteins from other species . PET9 belongs to the nuclear-encoded respiratory-defective mutants (pet mutants) collection, which represents a substantial fraction of the genetic information required for maintaining functional mitochondria in S. cerevisiae .

How is PET9 structurally and functionally different from other mitochondrial proteins?

Unlike many other mitochondrial precursor proteins, PET9 does not contain a transient N-terminal presequence that typically directs posttranslational localization to mitochondria . Instead, import information for PET9 is contained within the first 115 amino acid residues of the protein itself. Gene fusion studies have revealed that the N-terminal region of PET9 serves a dual function: it provides targeting to mitochondria and prevents membrane-anchoring sequences (located between residues 78 and 98) from prematurely stopping import at the outer mitochondrial membrane . This distinctive import mechanism makes PET9 an interesting model for studying alternative mitochondrial import pathways.

What experimental systems have been developed to study PET9 expression and function?

Several experimental systems have been developed to study PET9:

• Gene fusion approaches: PET9-lacZ gene fusions have been constructed to define sequences necessary for mitochondrial delivery of the PET9 protein in vivo .

• Recombinant expression systems: PET9 has been expressed in various systems including E. coli, yeast, baculovirus, and mammalian cells for biochemical and structural studies .

• Chimeric protein systems: A fusion protein combining the yeast mitochondrial ADP/ATP carrier (Anc2p/PET9) with iso-1-cytochrome c (Cyc1p) has been developed to increase the polar surface of the carrier and improve its crystallization properties .

• Genetic expression vs. plasmid overexpression: Both methods have been used to study PET9, with research showing that plasmid overexpression doesn't necessarily increase expression levels compared to homologous recombination methods .

What protein interaction networks involve PET9 in mitochondrial function?

PET9 participates in several key protein-protein interactions within mitochondria:

These interactions highlight PET9's central role in respiratory chain function and mitochondrial metabolism . Additionally, PET9 has been shown to interact with AAC1, another ADP/ATP carrier, with implications for mitochondrial outer membrane permeabilization and cytochrome c release in yeast apoptosis .

What are the optimal conditions for expressing and purifying functional recombinant PET9 protein?

Expression and purification of functional recombinant PET9 requires careful optimization:

Expression system selection:

• E. coli systems are suitable for basic structural studies but may lack post-translational modifications

• Yeast expression (homologous) provides the most native-like protein with proper folding and modification

• Baculovirus or mammalian expression systems may be preferred for complex functional studies

Purification protocol:

• Extraction with appropriate detergents: n-dodecyl-β-D-maltoside (DoDM) has been identified as the optimal detergent for solubilizing PET9

• Affinity purification: His6-tagged versions facilitate one-step purification

• Quality control: Functional assessment through nucleotide binding assays

• Storage: Glycerol-containing buffers at -20°C or -80°C for extended storage

Critical attention must be paid to preserving the native conformation during purification, as research has shown that carboxyatractyloside (CATR) and nucleotide-binding sites must be preserved in the purified protein to maintain functionality .

How can gene fusion approaches be effectively utilized to study PET9 localization and function?

Gene fusion approaches provide powerful tools for studying PET9:

Methodology for creating informative PET9 fusion constructs:

• Selection of fusion partner: β-galactosidase (lacZ) has been successfully used to track localization , while iso-1-cytochrome c (Cyc1p) improves crystallization properties

• Junction point determination: Critical for preserving function; the first 115 amino acids of PET9 contain sufficient information for mitochondrial targeting

• Expression control: Using either native PET9 regulatory sequences or strong promoters like PMA1

• Functional validation: Testing for complementation of pet9 mutant phenotypes on non-fermentable carbon sources to confirm activity

The Anc2-Cyc1(His6)p fusion protein has demonstrated particular utility as it retains transport activity while providing improved crystallization properties. This chimeric carrier can restore growth on non-fermentable carbon sources in yeast strains lacking functional ADP/ATP carrier, confirming its transport capability . Additionally, the Cyc1p moiety remains able to interact with cytochrome c oxidase with the same affinity as native Cyc1p, making this fusion particularly valuable for studying respiratory chain complex interactions .

What structural elements of PET9 are critical for substrate specificity and transport mechanism?

Molecular dynamics simulations and structural studies reveal key elements determining PET9's substrate specificity:

Critical structural features:

• Second basic patch: Residues K91, K95, and R187 are crucial for ADP recognition

• Tyrosine ladder: Y186, Y190, and Y194 contribute to substrate specificity

• Key residues: F191 and N115 in the upper cavity region are involved in discriminating between ADP and ATP

• Dual binding sites: Evidence suggests PET9 uses different sites for substrate recognition and conformational transition:

  • The upper region of the cavity for substrate discrimination

  • The central binding site for transport-associated conformational changes

This differentiated binding strategy allows PET9 to maintain high substrate specificity even during the dynamic transport process. Mutations in these key residues reduce ADP transport across membranes and induce defects in oxidative phosphorylation and ATP production in yeast .

How do pathogenic mutations in PET9 contribute to mitochondrial dysfunction and disease mechanisms?

Pathogenic mutations in PET9 (and its human homolog ANT1) reveal a novel disease mechanism:

Protein import clogging mechanism:

• Mutation consequences: Pathogenic missense mutations cause the protein to accumulate along the import pathway, obstructing general protein translocation into mitochondria

• Impact pathway: This blockage impairs mitochondrial respiration, cytosolic proteostasis, and cell viability independent of PET9's nucleotide transport activity

• Synergistic effects: Double mutations (e.g., Aac2 A128P,A137D) cause severe clogging primarily at the translocase of the outer membrane (TOM) complex

• Disease relevance: In mouse models, expression of "super-clogger" ANT1 variants leads to neurodegeneration and age-dependent dominant myopathy that phenocopy ANT1-induced human disease

Import assays using 35S-labeled Aac2p variants have demonstrated that while single mutations show minimal import defects, double mutations reduce IMM integration by >70% and increase association with the TOM complex . The transcriptional response to these mutations includes upregulation of CIS1 (hallmark of mitochondrial compromised protein import response) and stress response genes RPN4, HSP82, SSA3, and SSA4 .

What experimental approaches are most effective for studying PET9's ADP/ATP exchange activity?

Several complementary approaches provide insights into PET9's transport function:

Functional assay methodologies:

• In vivo complementation tests: Assessing growth restoration of pet9 mutants on non-fermentable carbon sources

• Reconstitution in liposomes: Purified PET9 can be reconstituted into liposomes for direct transport measurements

• Inhibitor binding studies: Using specific inhibitors like carboxyatractyloside (CATR) to assess binding site integrity

• Blue native PAGE analysis: For analyzing the assembly state of the carrier

• Mitochondrial import assays: Using 35S-labeled precursors to monitor transport kinetics and efficiency

When designing these experiments, it's important to note that while single-site mutations might not show dramatic effects in vitro, they can have significant consequences in vivo, particularly under stress conditions or when combined with other mutations .

What strategies can enhance the production and crystallization of recombinant PET9 for structural studies?

Improving PET9 crystallization remains challenging but several strategies have proven effective:

Production enhancement approaches:

• Synthetic propeptide design: Adding secretion-enhancing peptide cassettes can increase production by up to 190%

• Optimization parameters:

  • N-glycosylation sites

  • Net negative charge balance

  • Glycine-rich flexible linkers

Crystallization improvement strategies:

• Fusion protein approach: The Anc2-Cyc1(His6)p fusion increases polar surface area, improving crystallization properties

• Detergent selection: n-dodecyl-β-D-maltoside (DoDM) optimally preserves functional state

• Stable complex formation: Purifying PET9 in complex with its inhibitor carboxyatractyloside (CATR) increases stability

• Surface engineering: Modifying surface-exposed residues can reduce conformational flexibility

These strategies have opened new possibilities for crystallographic approaches to the yeast ADP/ATP carrier, potentially providing structural insights that complement functional studies and molecular dynamics simulations .